GenRx Voriconazole voriconazole 200mg tablet blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

voriconazole, Quantity: 200 mg

Prieinama:

Arrotex Pharmaceuticals Pty Ltd

INN (Tarptautinis Pavadinimas):

Voriconazole

Vaisto forma:

Tablet

Sudėtis:

Excipient Ingredients: magnesium stearate; polyvinyl alcohol; croscarmellose sodium; macrogol 8000; purified talc; titanium dioxide; lactose monohydrate

Vartojimo būdas:

Oral

Vienetai pakuotėje:

56

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Voriconazole is indicated for treatment of the following fungal infections: ? Invasive aspergillosis. ? Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). ? Serious fungal infections caused by Scedosporium spp and Fusarium spp. ? Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Produkto santrauka:

Visual Identification: White coloured, modified oval-shaped, biconvex film-coated tablets, engraved with "APO" on one side and "VOR 200" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2016-01-27